Sibrafiban versus aspirin to yield maximum protection from ischaemic heart events post acute coronary syndromes (the SYMPHONY trial)

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Sibrafiban versus aspirin to yield maximum protection from ischaemic heart events post acute coronary syndromes (the SYMPHONY trial)
Principal Investigator
Dr Ho, David Sai Wah   (Principal Investigator (PI))
Co-Investigator(s)
Professor Lau Chu Pak   (Co-Investigator)
Duration
8
Start Date
1998-05-01
Amount
400000
Conference Title
Sibrafiban versus aspirin to yield maximum protection from ischaemic heart events post acute coronary syndromes (the SYMPHONY trial)
Presentation Title
Keywords
post acute coronary syndromes (the SYMPHONY trial), Sibrafiban versus aspirin
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
N/A
Grant Type
Other Funding Scheme
Funding Year
1997
Status
Completed
Objectives
To compare the efficacy, safety, and tolerability of sibrafiban in two dose regimens to that of aspirin in patients following an episode of acute coronary syndrome (ACS) (i.e. Q-wave myocardial infarction (MI), non-Q-wave MI, or unstable angina).